(Circulation. 1999;99:2858-2860.)
© 1999 American Heart Association, Inc.
Brief Rapid Communications |
Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
From the Department of Cardiovascular Medicine, Kumamoto University School of Medicine (K.K., H.D., K.T., H.K., H.S., Y.M., R.T., T.S., H.O., S.S., M.Y., H.Y.), Kumamoto, Japan, and Japan Immunoresearch laboratories (T.N., K.N.), Takasaki, Japan.
Correspondence to Kiyotaka Kugiyama, MD, PhD, Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto City, Japan 860-8556. E-mail kiyo{at}gpo.kumamoto-u.ac.jp
Background—Remnant lipoproteins are atherogenic, but assays of remnants have not been available in routine clinical laboratories because of the lack of practical and validated methods. A simple and reliable method for such an assay, using an immunochemical approach, has recently been developed. This study prospectively examined whether remnant lipoprotein levels in fasting serum, measured by our method, may have prognostic value in patients with coronary artery disease (CAD).
Methods and Results—Remnant lipoprotein levels in fasting serum
were measured in 135 patients with CAD by an immunoaffinity mixed gel
containing anti-apolipoprotein (apo) A-1 and anti–apoB-100 monoclonal
antibodies. Patients were followed up for 
36 months until occurrence
of 1 of the following clinical coronary events: recurrent or
refractory angina pectoris requiring coronary
revascularization, nonfatal myocardial infarction,
or cardiac death. Kaplan-Meier analysis demonstrated a
significantly higher probability of developing coronary events
in patients with the highest tertile of remnant levels (>5.1 mg
cholesterol/dL; 75th percentile of distribution of remnant
levels) than in those with the lowest tertile of remnant levels (3.3
mg cholesterol/dL; 50th percentile of the distribution).
Higher levels of remnants were a significant and independent predictor
of developing coronary events in multivariate
Cox hazard analysis including the following covariates: extent
of coronary artery stenosis, age, sex, smoking,
hypertension, diabetes mellitus,
hypercholesterolemia, low HDL
cholesterol, and
hypertriglyceridemia.
Conclusions—Higher levels of remnant lipoproteins in fasting serum predict future coronary events in patients with CAD independently of other risk factors. Thus, measurement of fasting remnant levels, assessed by the current immunoseparation method, may be helpful in assessment of CAD risk.
Key Words: atherosclerosis • coronary disease • lipoproteins • prognosis • risk factors
This article has been cited by other articles:
 |
|
 |
|
  J. de Graaf, G. M. van der Vleuten, E. ter Avest, G. M. Dallinga-Thie, and A. F. H. Stalenhoef High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Satoh, A. Shimatsu, K. Kotani, N. Sakane, K. Yamada, T. Suganami, H. Kuzuya, and Y. Ogawa Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome Diabetes Care, January 1, 2007; 30(1): 144 - 146. [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Choi, Y. E. Jo, Y. K. Kim, S. M. Ahn, S. H. Jung, H. J. Kim, Y.-S. Chung, K. W. Lee, and D. J. Kim High Plasma Concentration of Remnant Lipoprotein Cholesterol in Obese Children and Adolescents Diabetes Care, October 1, 2006; 29(10): 2305 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koga, S. Sugiyama, K. Kugiyama, H. Fukushima, K. Watanabe, T. Sakamoto, M. Yoshimura, H. Jinnouchi, and H. Ogawa Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease Eur. Heart J., April 1, 2006; 27(7): 817 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Satoh, H. Adachi, M. Tsuruta, Y. Hirai, A. Hiratsuka, M. Enomoto, K. Furuki, A. Hino, T. Takeuchi, and T. Imaizumi High Plasma Level of Remnant-Like Particle Cholesterol in the Metabolic Syndrome Diabetes Care, October 1, 2005; 28(10): 2514 - 2518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Imke, B. L. Rodriguez, J. S. Grove, J. R. McNamara, C. Waslien, A. R. Katz, B. Willcox, K. Yano, and J. D. Curb Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?: The Honolulu Heart Study Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1718 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Lewis, M. Naples, K. Uffelman, N. Leung, L. Szeto, and K. Adeli Intestinal Lipoprotein Production Is Stimulated by an Acute Elevation of Plasma Free Fatty Acids in the Fasting State: Studies in Insulin-Resistant and Insulin-Sensitized Syrian Golden Hamsters Endocrinology, November 1, 2004; 145(11): 5006 - 5012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lopez-Miranda, G. Cruz, P. Gomez, C. MarIn, E. Paz, P. Perez-MartInez, F. J. Fuentes, J. M. Ordovas, and F. Perez-Jimenez The Influence of Lipoprotein Lipase Gene Variation on Postprandial Lipoprotein Metabolism J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4721 - 4728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Fukushima, S. Sugiyama, O. Honda, S. Koide, S. Nakamura, T. Sakamoto, M. Yoshimura, H. Ogawa, D. Fujioka, and K. Kugiyama Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type ii diabetes mellitus J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2219 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Carmena, P. Duriez, and J.-C. Fruchart Atherogenic Lipoprotein Particles in Atherosclerosis Circulation, June 15, 2004; 109(23_suppl_1): III-2 - III-7. [Abstract] [Full Text]
|
|
|
|
|
|
K. Oi, H. Shimokawa, J. Hiroki, T. Uwatoku, K. Abe, Y. Matsumoto, Y. Nakajima, K. Nakajima, S. Takeichi, and A. Takeshita Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 918 - 922. [Abstract] [Full Text]
|
|
|
|
|
|
T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype Circulation, April 27, 2004; 109(16): 1918 - 1925. [Full Text] [PDF]
|
|
|
|
|
|
H. K. Shin, Y. K. Kim, K. Y. Kim, J. H. Lee, and K. W. Hong Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase-Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activation: Prevention by Cilostazol Circulation, March 2, 2004; 109(8): 1022 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Moreno, J. Lopez-Miranda, C. Marin, P. Gomez, P. Perez-Martinez, F. Fuentes, R. A. Fernandez de la Puebla, J. A. Paniagua, J. M. Ordovas, and F. Perez-Jimenez The influence of the apolipoprotein E gene promoter (-219G/ T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males J. Lipid Res., November 1, 2003; 44(11): 2059 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Parhofer, E. Laubach, and P. H. R. Barrett Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients J. Lipid Res., June 1, 2003; 44(6): 1192 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Somekawa, H. Umeki, K. Kobayashi, S. Tomura, T. Aso, and H. Hamaguchi Effects of Hormone Replacement Therapy and Hepatic Lipase Polymorphism on Serum Lipid Profiles in Postmenopausal Japanese Women J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4766 - 4770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Olivieri, C. Stranieri, A. Bassi, B. Zaia, D. Girelli, F. Pizzolo, E. Trabetti, S. Cheng, M. A. Grow, P. F. Pignatti, et al. ApoC-III gene polymorphisms and risk of coronary artery disease J. Lipid Res., September 1, 2002; 43(9): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. W. de Sauvage Nolting, M. B. Twickler, G. M. Dallinga-Thie, R. J.A. Buirma, B. A. Hutten, J. J.P. Kastelein, and for the Examination of Probands and Relatives in S Elevated Remnant-Like Particles in Heterozygous Familial Hypercholesterolemia and Response to Statin Therapy Circulation, August 13, 2002; 106(7): 788 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Schaefer, J. R. McNamara, P. K. Shah, K. Nakajima, L. A. Cupples, J. M. Ordovas, and P. W.F. Wilson Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framingham Offspring Study Diabetes Care, June 1, 2002; 25(6): 989 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Jialal and S. Devaraj Remnant Lipoproteins: Measurement and Clinical Significance Clin. Chem., February 1, 2002; 48(2): 217 - 219. [Full Text] [PDF]
|
|
|
|
|
|
C. Koutsari, F. Karpe, S. M. Humphreys, K. N. Frayn, and A. E. Hardman Exercise Prevents the Accumulation of Triglyceride-Rich Lipoproteins and Their Remnants Seen When Changing to a High-Carbohydrate Diet Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1520 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukushima, A. Taniguchi, Y. Nakai, M. Sakai, K. Doi, K. Nin, T. Oguma, S. Nagasaka, K. Tokuyama, and Y. Seino Remnant-Like Particle Cholesterol and Insulin Resistance in Nonobese Nonhypertensive Japanese Glucose-Tolerant Relatives of Type 2 Diabetic Patients Diabetes Care, September 1, 2001; 24(9): 1691 - 1694. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Nestel, H. Shige, S. Pomeroy, M. Cehun, and J. Chin-Dusting Post-prandial remnant lipids impair arterial compliance J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Vogel, M. C. Corretti, and G. D. Plotnick The postprandial effect of components of the mediterranean diet on endothelial function J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1455 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Marcoux, P. N. Hopkins, T. Wang, E. T. Leary, K. Nakajima, J. Davignon, and J. S. Cohn Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state J. Lipid Res., September 1, 2000; 41(9): 1428 - 1436. [Abstract] [Full Text]
|
|
|
|
|
|
H. Doi, K. Kugiyama, H. Oka, S. Sugiyama, N. Ogata, S.-i. Koide, S.-i. Nakamura, and H. Yasue Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism Circulation, August 8, 2000; 102(6): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Waterworth, J. A. Hubacek, J. Pitha, J. Kovar, R. Poledne, S. E. Humphries, and P. J. Talmud Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI;-APOE cluster J. Lipid Res., July 1, 2000; 41(7): 1103 - 1109. [Abstract] [Full Text]
|
|
|
|
|
|
S. Hirany, D. O'Byrne, S. Devaraj, and I. Jialal Remnant-like Particle-Cholesterol Concentrations in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease Clin. Chem., May 1, 2000; 46(5): 667 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. N. Hodis Triglyceride-Rich Lipoprotein Remnant Particles and Risk of Atherosclerosis Circulation, June 8, 1999; 99(22): 2852 - 2854. [Full Text] [PDF]
|
|